FDA Commissioner Robert Califf (shown last year) expressed support for new drug pricing rules at the BIO conference this week.
BOSTON — The drug industry has spent the past year speaking against new mechanisms that could limit how much governments or insurers pay for certain new medicines. Robert Califf, the Food and Drug Administration chief, walked on stage Wednesday and…